Skip to main content

Table 2 The association of the clinical features and the expression of IMP3 with the prognosis of 73 patients with ovarian clear cell carcinoma

From: Clear cell carcinomas of the ovary: a mono-institutional study of 73 cases in China with an analysis of the prognostic significance of clinicopathological parameters and IMP3 expression

  DFS OS IMP3 expression Endometriosis
P P Positive Negative P Present Absent P
Age       0.097    0.071
  ≥60y 0.084 0.073 17 5 2 19
  <60y    29 22 15 36
Tumor size       0.222    0.415
  ≥15 cm 0.337 0.285 8 8 5 11
  <15 cm    38 19 12 44
Lateral       0.786    0.038
  Unilateral / / 37 21 40 17
  Bilateral    9 6 15 0
CA125       0.115    0.375
  Above normal 0.201 0.935 29 18 10 34
  Normal    8 1 3 5
Ascites       0.347    0.521
  Present 0.055 0.271 19 14 9 7
  Absent    24 11 24 27
Endometriosis       0.352 / / /
  Present 0.534 0.424 9 8
  Absent    36 19
Necrosis       0.260    0.296
  Present 0.377 0.499 16 13 5 24
  Absent    30 14 12 31
Papillary component       0.188    0.631
  Present 0.123 0.180 37 18 12 42
  Absent    9 9 5 13
Mitotic figures (/10 HPF)       0.488    0.660
  <10 0.712 0.947 40 24 12 44
  ≥10    6 2 1 6
Stage       0.074    0.038
  I <0.001 <0.001 19 17 12 23
  II–IV    27 10 5 32
DFS     44 18 0.175    
OS     44 18 0.012